New Data from SkylineDx Demonstrates Merlin CP-GEP Test’s Superior Melanoma Risk Stratification

— New data analysis clarifies misleading benchmarks released by a competitor; separate SkylineDx analysis demonstrates Merlin CP-GEP Test provides stronger metastatic-risk stratification and superior predictive accuracy for SLNB outcomes compared to 31-GEP/i31-SLNB, when evaluated under harmonized and scientifically rigorous conditions — Recent publication in early-stage melanoma shows Merlin CP-GEP Test correctly identifies High-Risk patients with […]

Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2025 and Announces Entry into Definitive Agreement for Financing

Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), China's leading used car retailer, today announced its unaudited financial results for the quarter ended September 30, 2025. Highlights for the Quarter Ended September 30, 2025 — Transaction volume was 15,904 units for the three months ended September 30, 2025, an increase of 37.0% from 11,606 units

GlucoModicum unveils Sofio(TM), the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD)

PRESS RELEASE — FOR IMMEDIATE RELEASE GlucoModicum unveils Sofio(TM), the world's first needle-free glucose monitor based on magneto-hydrodynamics (MHD) MHD technology draws micro-sample through skin; glucose is measured using established electrochemical sensor technology Single-day sensor system offers periodic and personalized monitoring alternative to continuous glucose monitoring devices Extensive multi-year clinical studies (N>2,000) have demonstrated accuracy,

FoRx Therapeutics Announces USD 50M Series A Financing, Enabling Clinical Data Readout for Potential Best-in-Class PARG Inhibitor

Funding to support Phase 1 clinical development of best-in-class PARG inhibitor candidate FORX-428 FORX-428 is potential new treatment option for patients whose cancers are resistant to, or have become resistant to, PARP inhibitors Initial data expected in mid-2026 from open-label Phase 1 study in advanced solid tumors Basel, Switzerland – December 18, 2025 – FoRx

GlucoModicum unveils Sofio(TM), the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD)

GlucoModicum unveils Sofio(TM), the world's first needle-free glucose monitor based on magneto-hydrodynamics (MHD) GlobeNewswire December 18, 2025 PRESS RELEASE — FOR IMMEDIATE RELEASE GlucoModicum unveils Sofio(TM), the world's first needle-free glucose monitor based on magneto-hydrodynamics (MHD) MHD technology draws micro-sample through skin; glucose is measured using established electrochemical sensor technology Single-day sensor system offers periodic

FoRx Therapeutics Announces USD 50M Series A Financing, Enabling Clinical Data Readout for Potential Best-in-Class PARG Inhibitor

FoRx Therapeutics Announces USD 50M Series A Financing, Enabling Clinical Data Readout for Potential Best-in-Class PARG Inhibitor GlobeNewswire December 18, 2025 Funding to support Phase 1 clinical development of best-in-class PARG inhibitor candidate FORX-428 FORX-428 is potential new treatment option for patients whose cancers are resistant to, or have become resistant to, PARP inhibitors Initial

VetMew, the AI-powered Pet Health Support App, Officially Launches in North American Market

VetMew, an AI-powered pet health support application, today announced its official launch in the North American market. The app delivers a groundbreaking tool designed to empower pet owners with immediate, accurate, and personalized AI-driven pet health guidance, directly addressing the region's growing pet care challenges. VetMew is a dedicated pet health support app that offers

GeeTest Introduces Advanced Business Rules Engine to Empower Businesses with Intelligent, Automated Decision-Making

GeeTest, a global leader in bot management and online security solutions serving over 360,000 enterprises worldwide, today highlights its powerful Business Rules Engine. This advanced no-code/low-code platform enables organizations to build flexible, automated risk control systems that deliver precise, real-time decision-making without relying on complex coding. Businesses today must continually optimize operations, strengthen risk controls,

Senior Helpers of Fairfield & New Haven, CT, Achieves Prestigious CHAP Age-Friendly Care at Home Certification

Senior Helpers, the nation's premier provider of in-home senior care services, is the first private duty in-home care provider inthe United Statesto be Age-Friendly Care at Home certified by Community Health Accreditation Partners (CHAP). On December 12th, 2025,locally ownedSenior Helpers of Fairfield & New Haven Counties joined the list of Senior Helpers CHAP Age-Friendly Care

ANTA Group’s Partnership with UNHCR Empowers 300,000 Displaced Children Through Education and Sports

Three-Year Partnership Delivers Greater Access to Learning, Safety, and Sport for Displaced Youth ANTA Group's “Moving for Change” partnership with UNHCR, the UN Refugee Agency, is expected to have supported more than 300,000 displaced children and youth in Africa over the past three years. At this week's Global Refugee Forum Progress Review in Geneva, the

Scroll to Top